With revenue of $15.5 million, 81qd is a small agency built on the belief that its combination of AI, real-world data and human intelligence can solve many difficult challenges in biopharma marketing and medical communications.
Because it can bring data to life, its clients can use that data to bring their differentiation to life. When it started back in 2006, a small, 81mg dose of aspirin taken once a day, or qd, was the precise dosage for heart attack prevention.
Its goal is to apply its deep data science experience and medical knowledge to the latest advances in AI and RWD, creating proprietary solutions. And it works with clients to ensure that analytics are standardized through commercial strategy and execution.
With a multidisciplinary team of 38 data scientists, medical strategists and marketing professionals, the agency is as adept at strategic planning as it is at tactical execution. With offices in New York, Atlanta and Hoboken, New Jersey, solutions include identifying and profiling academic and clinical leaders, segmentation and targeting healthcare providers and therapy adherence analytics.
It’s recently added such services as holistic network mapping to connect HCPs based on clinical, academic and industry-sponsored engagements, social media and affiliation relationships; market sizing/clinical journey analytics; and social/digital sentiment analysis.
Owned by Novo Holdings, a subsidiary of the Novo Nordisk Foundation, it’s deeply committed to charitable work, supporting health awareness campaigns such as Rare Disease Day and contributes to charities such as the National Children’s Cancer Society.
Deloitte Digital, positioned at the intersection of consulting and creativity, continues to impress with its commitment to delivering scalable ideas in complex organizations, drawing heavily on its parent company’s view of the healthcare ecosystem. This year’s highlights include stellar efforts for NYU Langone Health and SheCanSTEM, a Super Bowl PSA and a national social impact campaign.